Skip to content
Review

Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships.

Sep 2026 · European journal of medicinal chemistry · Vol 320, pp. 119358 · 0 citations · 172 references
Medicine

TL;DR

Neolignans are potential natural product-derived anticancer leads; rational SAR-guided optimization, sophisticated delivery methods, and computational drug development may speed up their clinical translation.

Abstract

Many therapeutic plants contain structurally varied natural phenylpropanoid dimers called neolignans, which are biosynthesized via non-8,8' oxidative coupling routes. They are attractive candidates for anticancer drug development because of their chemical diversity, multitarget pharmacological activity, and ability to alter neoplastic pathways. This study compiles recent developments in the isolation, classification, biosynthesis, morphological diversity, structure-activity relationships (SAR), mechanism of action, and formulation techniques of anticancer neolignans. Using Google Scholar, Science Direct, Web of Science, and Bentham Science databases, a comprehensive literature search was carried out in accordance with PRISMA 2020 principles, encompassing literature accessible up to June 2026. The qualitative analysis includes 179 peer-reviewed studies based on predetermined criteria. For isolation, solvent extraction and chromatographic methods were frequently employed, and structural characterisation was made easier by NMR, HPLC, HRMS, and IR. Significant anticancer action has been demonstrated by various neolignan derivatives; modifications such as fluorination, methoxylation, heterocyclic incorporation, and hybridization improved potency and selectivity. Neolignans exert anticancer effects through apoptosis, cell-cycle arrest, autophagy, and regulation of the MAPK, Wnt/β-catenin, NF-κB, and PI3K/Akt/mTOR pathways. Micelles, liposomes, and nanoparticles are some examples of Nano carrier-based formulations that further enhance solubility, bioavailability, and antitumor effectiveness. All things considered, neolignans are potential natural product-derived anticancer leads; rational SAR-guided optimization, sophisticated delivery methods, and computational drug development may speed up their clinical translation.

View source

Similar papers

Review Open access Aug 2026

Coumarin-indole hybrid pharmacophores in medicinal chemistry: design, synthesis, biological activities, and structure-activity relationships

Coumarin-indole hybrid pharmacophores have emerged as promising multifunctional scaffolds in medicinal chemistry by integrating two privileged heterocyclic frameworks with complementary pharmacological properties. This review systematically summarizes recent advances in the design strategies, synthetic approaches, biol...

Abinash Sharma, Aadhat Kattel, P. P. Prabhu · 0 citations
Review Sep 2026

Sponge Derived Macrolides (2000-2023): Chemical Diversity, Mechanistic Insights and Therapeutic Potential.

This narrative mini-review covers the period from 2000 to 2023, focusing on the chemical, mechanistic insights, and therapeutic potential of 96 novel macrolides isolated from marine sponge species, showing promising in vivo antitumor efficacy and enhanced pharmacokinetic profiles.

Afsona Khatun, Ritabrata Koley, Shaileyee Das · 0 citations
Open access Sep 2026

Discovery of bioactive aromatic butenamide derivatives: synthesis, antifungal activity, and mechanistic elucidation

Plant pathogenic fungi pose a serious threat to global agricultural production. Traditional fungicides have become increasingly prominent due to multi-drug resistance. It is urgent to develop new and efficient fungicides with unique mechanisms of action that can effectively overcome drug resistance. The...

Wen-Jie Hu, Jing-Yi Yu, Xue-Bin Zhang et al. · 0 citations
Review Open access Oct 2026

A comprehensive review on synthesis and anticancer evaluation of triazole chalcone hybrids

Cancer remains one of the leading causes of mortality worldwide, creating an ongoing need for new and potent therapeutic agents with enhanced safety and selectivity. Among various heterocyclic hybrids, triazole based chalcone derivatives have drawn attention due to their structural versatility and broad spectrum of bio...

Latha Jogi, Venkatachalam H · 0 citations
Review Aug 2026

Recent progress in the natural products research on the phenanthrene-fused indolizidine ring scaffold: Structural diversity, biological activity, and synthetic studies.

This review synthesizes the scattered research findings in this field and clarifies the structure-activity and structure-toxicity relationships, thereby providing a systematic theoretical framework for the molecular design, targeted synthesis, and innovative drug development of this class of alkaloids.

Xin-Yu Li, Yimeng Wang, Xiao-Qing Chang et al. · 0 citations
Review Aug 2026

Pyrimidine-containing Heterocyclic Anticancer Agents: Systematic Development, SAR, and Mechanistic Pathways.

Pyrimidine-containing hybrids emerge as a privileged scaffold in medicinal chemistry for the development of effective, multitargeted anticancer agents with improved pharmacological profiles and reduced off-target effects.

Bhim Singh, Ankita Devi, V. Jaitak · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.